Metric Deep Dive: Understanding Sensei Biotherapeutics Inc (SNSE) Through its Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $0.34 in the prior trading day, Sensei Biotherapeutics Inc (NASDAQ: SNSE) closed at $0.30, down -10.58%. In other words, the price has decreased by -$10.58 from its previous closing price. On the day, 0.54 million shares were traded.

Ratios:

Our goal is to gain a better understanding of SNSE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.82 and its Current Ratio is at 6.82. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.03.

On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $5.

Berenberg Downgraded its Buy to Hold on July 01, 2021, while the target price for the stock was maintained at $12.

Stock Price History:

Over the past 52 weeks, SNSE has reached a high of $0.87, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -14.70%, while the 200-Day Moving Average is calculated to be -34.88%.

Shares Statistics:

A total of 25.21M shares are outstanding, with a floating share count of 16.52M. Insiders hold about 34.48% of the company’s shares, while institutions hold 7.69% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.